Cipla USA, Inc. is the wholly owned US subsidiary of Cipla Limited, supplying patients with access to medicines and operating manufacturing units in New York and Massachusetts. Its US-market production includes tablets, capsules, and inhalation products; the company says its US journey began in 1984, when Cipla became the first Indian company to receive US FDA approval. Cipla Limited dates its origins to 1935 and describes a global pharmaceutical business with 47 manufacturing sites and a portfolio of more than 1,500 products.